Bottom line
What does XLV hold?
XLV held 65 positions as of Jun 30, 2026. Its largest holding is Eli Lilly & Co at 16.51% of the fund, and the top 10 positions add up to 61.5%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Aug 28, 2026
XLV top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | Stocks | 16.51% | $6.7B |
| 2 | Johnson & Johnson | Stocks | 10.64% | $4.3B |
| 3 | AbbVie Inc | Stocks | 7.74% | $3.1B |
| 4 | UnitedHealth Group Inc | Stocks | 6.57% | $2.7B |
| 5 | Merck & Co Inc | Stocks | 5.52% | $2.2B |
| 6 | Amgen Inc | Stocks | 3.40% | $1.4B |
| 7 | Thermo Fisher Scientific Inc | Stocks | 3.24% | $1.3B |
| 8 | Abbott Laboratories | Stocks | 2.75% | $1.1B |
| 9 | Gilead Sciences Inc | Stocks | 2.73% | $1.1B |
| 10 | Intuitive Surgical Inc | Stocks | 2.45% | $995.0M |
| 11 | Pfizer Inc | Stocks | 2.39% | $969.6M |
| 12 | CVS Health Corp | Stocks | 2.30% | $932.5M |
| 13 | Vertex Pharmaceuticals Inc | Stocks | 2.19% | $890.7M |
| 14 | Danaher Corp | Stocks | 2.09% | $847.7M |
| 15 | Bristol-Myers Squibb Co | Stocks | 2.05% | $831.3M |
| 16 | Stryker Corp | Stocks | 1.89% | $767.4M |
| 17 | Medtronic PLC | Stocks | 1.75% | $709.6M |
| 18 | McKesson Corp | Stocks | 1.58% | $641.7M |
| 19 | Elevance Health Inc | Stocks | 1.46% | $593.3M |
| 20 | Cigna Group/The | Stocks | 1.27% | $515.2M |
| 21 | Boston Scientific Corp | Stocks | 1.10% | $448.2M |
| 22 | Regeneron Pharmaceuticals Inc | Stocks | 1.08% | $440.2M |
| 23 | HCA Healthcare Inc | Stocks | 1.05% | $427.7M |
| 24 | Cardinal Health Inc | Stocks | 0.97% | $393.1M |
| 25 | Cencora Inc | Stocks | 0.96% | $388.9M |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026